| Donor condition
(recipient number) |
EF
% |
ESV
μl |
EDV
μl |
AWTd
mm |
PWTd
mm |
Border zone
mm |
Infarct
mm |
| Young (n = 15)
Baseline
Day 2 post-MI
Day 28 post-MI |
50.1±2.2
32.1±3.4*
39.0±5.9*‡ |
33.2±3.4
42.1±5.6*
41.2±6.7† |
66.4±5.1
61.9±7.3
67.6±9.6◊ |
0.73±0.04
0.72±0.04 |
0.69±0.05
0.67±0.05 |
0.63±0.04
0.59±0.04‡ |
0.51±0.06
0.49±0.06 |
| Middle-aged (n = 12)
Baseline
Day 2 post-MI
Day 28 post-MI |
50.6±4.0
31.7±4.1*
32.6±3.8*¤ |
34.4±3.4
42.6±8.9*
56.4±12.3*‡⌂ |
69.5±4.0
62.5±12.8
83.5±16.3#◊⌂ |
0.73±0.04
0.70±0.03 |
0.73±0.04
0.70±0.03 |
0.62±0.04
0.55±0.08‡ |
0.52±0.08
0.46±0.09◊ |
| Old (n = 17)
Baseline
Day 2 post-MI
Day 28 post-MI |
50.1±4.6
32.3±4.3*
23.8±5.5*§Ω |
33.1±5.9
43.0±9.0†
78.3±28.1*‡Ω |
65.9±8.6
63.5±11.5
101.7±31.2†§║∞ |
0.71±0.03
0.63±0.05§Ω |
0.71±0.02
0.66±0.04‡∆ |
0.61±0.07
0.47±0.07§║∞ |
0.51±0.05
0.38±0.06§¤∞ |
| HBSS (n = 14)
Baseline
Day 2 post-MI
Day 28 post-MI |
50.1±4.4
31.8±3.5*
21.4±6.4*§Ω |
33.3±4.7
42.9±6.3*
82.5±26.0*‡Ω |
66.7±6.3
62.9±7.9
103.4±25.5*§║∞ |
0.73±0.02
0.67±0.04§Ω |
0.71±0.02
0.70±0.01 |
0.63±0.03
0.46±0.09§║∞ |
0.54±0.06
0.33±0.09§Ω |
AWTd, anterior wall thickness in diastole; BMCs, bone marrow cells; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; HBSS, Hank’s balanced
salt solution; MI, myocardial infarction; PWTd, posterior wall thickness in diastole.